找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cervagem; A new prostaglandin Sultan M. M. Karim ((Symposium Chairman and Procee Conference proceedings 1983 MTP Press Limited 1983 Pessar

[復(fù)制鏈接]
樓主: T-Lymphocyte
31#
發(fā)表于 2025-3-26 21:02:54 | 只看該作者
32#
發(fā)表于 2025-3-27 03:15:11 | 只看該作者
33#
發(fā)表于 2025-3-27 08:24:35 | 只看該作者
Lecture Notes in Computer ScienceIn this first Cervagem International Symposium we have heard today the detailed results of closely monitored, controlled clinical trials with this new product. In many cases it has been our good fortune to receive the information from the best possible source — the investigators themselves.
34#
發(fā)表于 2025-3-27 09:45:40 | 只看該作者
35#
發(fā)表于 2025-3-27 14:31:03 | 只看該作者
Welfare effects of parallel trade,I am sure all of you will agree with me that this has been a stimulating afternoon. I am not going to detain you any longer by summarizing this afternoon’s proceedings which will be published later.
36#
發(fā)表于 2025-3-27 18:05:39 | 只看該作者
Clinical applications of prostaglandins in obstetrics and gynaecology,The use of prostaglandins in obstetrics and gynaecology is now firmly established. Most applications in this area are based on the ability of prostaglandins to modify the activity of the human uterus. This property was first recognized in 1930 and has since been confirmed by numerous investigators using pure prostaglandins.
37#
發(fā)表于 2025-3-28 01:57:08 | 只看該作者
38#
發(fā)表于 2025-3-28 02:49:52 | 只看該作者
39#
發(fā)表于 2025-3-28 08:19:47 | 只看該作者
Cervagem future development: proposed clinical evaluation by the prescriber,For the purpose of this evaluation, the normal prescribing information for Cervagem has been transcribed into a protocol format. Cervagem is indicated for ., and the protocol is set out here.
40#
發(fā)表于 2025-3-28 14:19:33 | 只看該作者
,Chairman’s concluding remarks,I am sure all of you will agree with me that this has been a stimulating afternoon. I am not going to detain you any longer by summarizing this afternoon’s proceedings which will be published later.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 10:03
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
峨山| 潞西市| 望江县| 清涧县| 犍为县| 伊宁县| 麻栗坡县| 郸城县| 马公市| 赤水市| 肇庆市| 兰坪| 和林格尔县| 垦利县| 石泉县| 府谷县| 陕西省| 洞口县| 班玛县| 邢台县| 阳山县| 沙雅县| 全椒县| 泸溪县| 哈密市| 常州市| 武隆县| 铜川市| 纳雍县| 惠水县| 泸水县| 定远县| 石阡县| 正阳县| 兴山县| 即墨市| 商水县| 湘潭市| 义马市| 汉川市| 拉萨市|